Combination Comprising Parthenolide For Use In The Treatment Of Alzheimer's Disease And Other Neurodegenerative Disorders

Handle URI:
http://hdl.handle.net/10754/594860
Title:
Combination Comprising Parthenolide For Use In The Treatment Of Alzheimer's Disease And Other Neurodegenerative Disorders
Authors:
Bajic, Vladimir B. ( 0000-0001-5435-4750 ) ; Essack, Magbubah ( 0000-0003-2709-5356 )
Assignee:
King Abdullah University of Science and Technology
Abstract:
The present invention generally concerns particular methods and compositions for treatment of a neurodegenerative disease, such as Alzheimer's Disease. In particular embodiments, there is a composition comprising Parthenolide and a second agent, including an inhibitor of TLR4/MD-2/CD14, nAChR agonist, Resatorvid, Curcumin, Tilorone or a Tilorone analog, or a combination thereof.
KAUST Department:
Computer, Electrical and Mathematical Sciences and Engineering (CEMSE) Division; Computational Bioscience Research Center (CBRC)
Issue Date:
18-Jun-2015
Submitted date:
2014-11-20
Type:
Patent
Application Number:
US 20150164858 A1
Patent Status:
Published Application
Additional Links:
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220150164858%22.PGNR.&OS=DN/20150164858&RS=DN/20150164858; http://assignment.uspto.gov/#/search?adv=publNum:20150164858; http://www.google.com/patents/US20150164858; http://worldwide.espacenet.com/publicationDetails/biblio?CC=US&NR=2015164858A1&KC=A1&FT=D
Appears in Collections:
Patents; Computational Bioscience Research Center (CBRC); Computer, Electrical and Mathematical Sciences and Engineering (CEMSE) Division

Full metadata record

DC FieldValue Language
dc.contributor.authorBajic, Vladimir B.en
dc.contributor.authorEssack, Magbubahen
dc.date.accessioned2016-01-26T10:35:57Zen
dc.date.available2016-01-26T10:35:57Zen
dc.date.issued2015-06-18en
dc.date.submitted2014-11-20en
dc.identifier.urihttp://hdl.handle.net/10754/594860en
dc.description.abstractThe present invention generally concerns particular methods and compositions for treatment of a neurodegenerative disease, such as Alzheimer's Disease. In particular embodiments, there is a composition comprising Parthenolide and a second agent, including an inhibitor of TLR4/MD-2/CD14, nAChR agonist, Resatorvid, Curcumin, Tilorone or a Tilorone analog, or a combination thereof.en
dc.relation.urlhttp://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220150164858%22.PGNR.&OS=DN/20150164858&RS=DN/20150164858en
dc.relation.urlhttp://assignment.uspto.gov/#/search?adv=publNum:20150164858en
dc.relation.urlhttp://www.google.com/patents/US20150164858en
dc.relation.urlhttp://worldwide.espacenet.com/publicationDetails/biblio?CC=US&NR=2015164858A1&KC=A1&FT=Den
dc.titleCombination Comprising Parthenolide For Use In The Treatment Of Alzheimer's Disease And Other Neurodegenerative Disordersen
dc.typePatenten
dc.contributor.departmentComputer, Electrical and Mathematical Sciences and Engineering (CEMSE) Divisionen
dc.contributor.departmentComputational Bioscience Research Center (CBRC)en
dc.description.statusPublished Applicationen
dc.contributor.assigneeKing Abdullah University of Science and Technologyen
dc.description.countryUnited Statesen
dc.identifier.applicationnumberUS 20150164858 A1en
All Items in KAUST are protected by copyright, with all rights reserved, unless otherwise indicated.